Hearscape
← Organizations
Sponsor / Institution

Assistance Publique - Hopitaux de Paris

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
4
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
4
0 open data checks
Company / Institution Links
0 / 4
industry vs non-industry records
Competitive Density
7
Pipeline Velocity
85
Completion Signal
50

Programs by Stage

Phase 32
Interventional/NA1
Observational/NA1

Trial / Program Status

Active4

Modality Mix

Small Molecule2
Cochlear/Auditory Implant1
Hearing Aid/Software1

Indication Coverage

Hearing Loss4
Sensorineural Hearing Loss2
Conductive Hearing Loss1
Congenital CMV-Associated Hearing Loss1
Congenital Hearing Loss1
Sudden Hearing Loss1

Program Types

Therapeutic2
Device1
Software/Neurotech1

Population Tags

pediatric3
congenital2
sensorineural2
adult1
bilateral1
bone-conduction1
cmv1
cochlear-implant1
conductive1
ear-atresia1

Strong-Evidence Records

0 records
No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

4 checked · 0 open checks
Valganciclovir for congenital CMV-associated hearing loss
Details checked
Small MoleculePhase 3Active

Oral valganciclovir, a ganciclovir prodrug antiviral, evaluated to suppress congenital cytomegalovirus replication and reduce or stabilize CMV-associated sensorineural hearing-loss progression in infants and young children.

Data checks: generic-drug-study-cluster, not-industry-sponsored-pipeline-program
AP-HP SERORL aspirin and folic acid SSNHL study
Details checked
Small MoleculePhase 3Active

Adjunctive aspirin 100 mg/day plus folic acid 5 mg/day, added to standard corticosteroid care, being evaluated for sudden sensorineural hearing loss based on a microvascular/homocysteine hypothesis.

Data checks: institution-led-study, not-yet-recruiting
AP-HP APLOSIA bilateral Cochlear Osia pediatric study
Details checked
Cochlear/Auditory ImplantInterventional/NAActive

Not-yet-recruiting AP-HP study evaluating bilateral Cochlear Osia/OSIA2 active transcutaneous bone-conduction implantation in children with high-grade microtia or ear atresia, including unilateral-versus-bilateral activation comparisons.

Data checks: institution-led-study, not-yet-recruiting
AP-HP LENA language-environment cochlear-implant study
Details checked
Hearing Aid/SoftwareObservational/NAActive

Recruiting AP-HP observational study using the LENA language-environment recording and analysis system plus parent feedback to evaluate language-environment support after early pediatric cochlear implantation.

Data checks: institution-led-study, active-recruiting